Alzheimer Disease
Alzheimer Disease
复制标题
DOI：
10.1016/j.nurpra.2017.10.014
复制
发表时间：
2018-03-01
影响因子：
1
通讯作者：
McLea, Samantha
中科院分区：
文献类型：
--
作者：
Ulep, Maileen Gloriane;Saraon, Simrit Kaur;McLea, Samantha
阿尔茨海默病（AD）是一种影响认知和行为的进行性神经退行性疾病，其临床持续时间约为8-10年。它影响到家庭，而不仅仅是个人。到2050年，全球将有超过1亿人受到AD的影响。记忆障碍是最常见的表现症状;然而，其他症状也可能表现为精神障碍。因此，它是必要的提供者，特别是那些在初级保健，能够识别，诊断和管理这一患者群体。目前没有疾病修饰疗法;然而，可以改善症状的治疗是可用的。
Alzheimer disease (AD), a progressive neurodegenerative disorder that affects cognition and behavior, has a clinical duration of approximately 8-10 years. It affects families, not just the individual. By 2050, more than 100 million individuals will be affected by AD worldwide. Memory impairment is the most common presenting symptom; however, others may present atypically. Thus, it is imperative for providers, especially those in primary care, to be able to recognize, diagnose, and manage this patient population. There are currently no disease modifying therapies; however, treatments that can ameliorate symptoms are available.